The Health Resources and Services Administration (HRSA) administers section 340B of the Public Health Service Act (PHSA), referred to as the ``340B Drug Pricing Program'' or the ``340B Program.'' This final rule will apply to all drug manufacturers that are required to make their drugs available to covered entities under the 340B Program. This final rule sets forth the calculation of the 340B ceiling price and application of civil monetary penalties (CMPs).
Document
340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation
The Health Resources and Services Administration (HRSA) administers section 340B of the Public Health Service Act (PHSA), referred to as the ``340B Drug Pricing Program'' or the...
Legal Citation
Federal Register Citation
Use this for formal legal and research references to the published document.
82 FR 1210
Web Citation
Suggested Web Citation
Use this when citing the archival web version of the document.
“340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties Regulation,” thefederalregister.org (January 5, 2017), https://thefederalregister.org/documents/2016-31935/340b-drug-pricing-program-ceiling-price-and-manufacturer-civil-monetary-penalties-regulation.